Where Innovations Meets Personalized and Precision Medicine

Original article
Original article
Original article
Original article

 

 

Journal Metrics
of Volumes 10
Number of Issues 38
Number of Articles 184
Number of Contributors 354
Article View 69,222
PDF Download 56,868
View Per Article 376.21
PDF Download Per Article 309.07
 
Number of Submissions 71
Acceptance Rate 65
Time to Accept (Days) 33

Personalized and Precision Medicine Journal is an open-access access double-blind peer peer-reviewed publication which is published by AmitisGen TECH Dev Group, concerned with new concepts and findings in areas related to Personalized & Precision Medicine issues. PPMJ is a quarterly publication that welcomes original, review, novel, and high-impact articles in the journal's scope (See journal scope). PPMJ follows the Committee on Publication Ethics (COPE) and complies with the highest ethical standards in accordance with ethical laws. All submitted manuscripts are checked for similarity through a trustworthy software named iThenticate to be assured about its originality and then rigorously peer-reviewed by the reviewers.

  (Read more about this journal...)


        https://ecc.isc.ac/showJournal/39838


 

Advancing Remyelination Therapies in Multiple Sclerosis: Beyond Inflammation Control

Advancing Remyelination Therapies in Multiple Sclerosis: Beyond Inflammation Control

Pages 1-10

https://doi.org/10.22034/ppmj.2025.732264

Sevak Hatamian

Abstract Multiple sclerosis (MS) is a long‐term disease that is frequently progressive and affects the central nervous system (CNS). This in turn breaks down the myelin sheath the protective covering around nerve fibers. Damage to myelin leads to a breakdown in nerve communication and can cause a number of neurological conditions. This study examines recent approaches towards increasing remyelination in the multiple sclerosis (MS) population as the protection of oligodendrocytes and promotion of remyelination are essential therapeutic goals. Materials and methods: A search was performed in national and international databases with the use of specific keywords. This search resulted in the identification of 235 articles, on “remyelination” and “multiple sclerosis”. Seventy articles were included in this review from 2000 up to 2020. These findings lead to the conclusion that already established immunomodulatory therapies have some benefits for reduction of myelin breakdown, but are rather poor at promoting remyelination, most notably in progressive MS.Controversially during the last years a change has been made towards compounds targeting (symptomatic) inflammation as well as remyelination. These interventions may optimize function and may promote axonal conduction. These strategies, including stem cell therapy, growth factors, small molecules and gene therapies hold promise in future treatment of MS. Not only are they trying to stop further loss of myelin, but also attempt to repair what damage has already been done.

Advancements in 3D Bioprinting for Functional Tissue Engineering in Regenerative Medicine

Pages 11-19

https://doi.org/10.22034/ppmj.2025.732267

Farnaz Roshan Mehr, Fatemeh Gabeleh

Abstract 3D bioprinting is a breakthrough fabrication technology in regenerative medicine It offers great promise for fabricating hierarchical and heterogeneous tissues and organs with similar architecture as those of the natural ones. This review discusses recent advances in 3D bioprinting and the progress made for fabricating functional tissues, which have regenerative therapy applications. We cover the development of bioprinting methodologies, bioink composition and optimization, and incorporation of cellular and molecular signals for improving tissue function. An overview of the literature on key applications in skin, cartilage, bone and cardiovascular tissues is provided, including both preclinical achievements and clinical barriers/goals. In addition, we also talk about the contribution of bioprinted tissues for drug screening, disease modelling and personalized medicine. Regulatory and ethical aspects associated with the clinical translation of bioprinted tissues are also highlighted in this review. We present an up-to-date analysis of the recent literature (including studies from Nature, The Lancet, and BMC) as well as a data-rich viewpoint on 3D bioprinting to date in regenerative medicine.

Chitosan-Cefixime as Personalized Antibacterial Agent Against E. coli O157:H7

Pages 20-24

https://doi.org/10.22034/pmj.2025.2044598.1045

Romina Hosseinzadeh, Reyhaneh Sadat Moosavi-Kohnehsari

Abstract Antibiotics are widely accessible. Nevertheless, food-borne bacteria exhibit a vast array of resistance. Utilizing natural ingredients like chitosan and chitosan-cefixime nanoparticles, which have potent antibacterial qualities, in conjunction with innovative technologies like chitosan loaded with antibiotics, the present research seeks to combat germs that are resistant to many drugs. Five strains of Escherichia coli O157:H7 were utilized to determine antibiotic resistance. The antibacterial properties of free cefixime and chitosan-cefixime nanoparticles were evaluated against strains of harmful bacteria. The findings demonstrated that E. coli O157:H7 comparatively had significant resistance to many antibiotics.
On the other hand, c chitosan-cefixime nanoparticles showed strong antibacterial activity against E. coli O157:H7, but free cefixime did not demonstrate any inhibitory zone. When compared to strains 1, 2, 3, 4, and 5 of E. coli O157:H7, the inhibition zones of chitosan-cefixime nanoparticles were 23.3 mm, 19.8 mm, 16.9 mm, 18.2 mm, and 22.4 mm, respectively. According to the results, chitosan-cefixime nanoparticles have better antibacterial action against dangerous pathogens than free cefixime. Therefore, using chitosan-cefixime nanoparticles for food preservation could be suggested.

Metabolic Syndrome and Inflammatory Diseases: A Comprehensive Review of Mechanisms and Management

Pages 25-35

https://doi.org/10.22034/pmj.2025.2050171.1051

Akram Sadat Ahmadi, Atefeh Valaei

Abstract Rheumatic inflammatory diseases, besides affecting joints and other bodily systems, are linked to heightened mortality and morbidity. Cardiovascular reasons are among the most prevalent mortality factors in individuals with these disorders, attributable to the disease's etiology and pathophysiology, chronic inflammation, and the pharmacological treatments employed. Although rheumatoid arthritis, systemic lupus erythematosus, psoriatic arthritis, and gout exhibit distinct pathophysiology and symptoms, persistent inflammation remains their shared pathophysiological characteristic. Metabolic syndrome has recently been linked to several of these disorders. The investigation of metabolic syndrome in inflammatory rheumatic diseases is significant for multiple reasons, including its correlation with cardiovascular disease onset, the emergence of a pre-inflammatory condition, treatment selection, and associated monitoring. This review article initially explores the significance of metabolic syndrome in rheumatic diseases, followed by a detailed analysis of each condition individually. This study concludes, through a review of previous studies, that abdominal obesity in rheumatoid arthritis and lupus patients, abdominal obesity and hypertension in psoriatic arthritis patients, and hypertriglyceridemia and hypertension in gout are significant elements of metabolic syndrome warranting increased focus.

New FRET-Base Approach for Detection of HPV High Risk Genotype by DNA Capturing

Pages 36-42

https://doi.org/10.22034/pmj.2025.2051326.1053

Ghazal Emadian

Abstract Human Papillomavirus (HPV) is a highly prevalent virus responsible for several types of cancers, including cervical, throat, and anogenital cancers. Early detection and diagnosis are crucial for preventing the progression of HPV-related diseases. In this study, we introduce a new approach based on Förster Resonance Energy Transfer (FRET) method to identify viral DNA, was designed for the conserved region of the L1 gene sequence in high-risk genotypes 16, 18, 31 and 33. In order to create suitable temperature conditions for the attachment and also to identify the fluorescent signal, real time PCR device was used. The results of the specificity test showed 100% specificity and the limit of detection level of the method was reported to be 1000 copies/µl of the virus in the sample. The results of clinical sensitivity in the range of 86-96% between deferent genotype and the rate of false negative results was in the range of 14-22%. Based on this, it can be said that maybe the developed method cannot be proposed as a suitable alternative, but due to the response time and lower cost, it can be proposed as a quick screening method.

Managing Inflammation in Cancer Therapy: Effects of Inflammation Control on Metastasis and Treatment Response

Pages 43-53

https://doi.org/10.22034/ppmj.2025.2066236.1065

Maryam Abbasi Saeidi, Mina i Ekrami Noghab

Abstract Chronic inflammation is a pivotal element in the onset and advancement of cancer. It is crucial in tumor initiation, survival, metastasis, and therapeutic resistance. This study seeks to thoroughly examine the intricate relationship between inflammation and cancer, emphasizing the role of inflammatory processes in tumor formation and their influence on cancer therapy responses. We will investigate the molecular processes behind inflammation-induced cancer progression, analyze how inflammation affects metastasis, and assess its effects on the effectiveness of treatments like chemotherapy, immunotherapy, and targeted therapies. Furthermore, we will investigate prospective therapeutic approaches for addressing inflammation in cancer treatment, emphasizing the necessity for specific modulation to enhance treatment efficacy while mitigating adverse consequences such as immune suppression or heightened infection risk. The report finishes with a discussion on prospective research avenues focused on optimizing inflammation-targeting techniques to augment the efficacy of cancer therapies and better patient outcomes. Ultimately, a deeper understanding of inflammation’s dual role in cancer could pave the way for innovative, more personalized treatment strategies that improve survival and quality of life for patients.

The Multifaceted Role of CD154 in SLE: Pathogenesis, Receptor Interactions, and Emerging Therapies

Articles in Press, Accepted Manuscript, Available Online from 01 May 2025

https://doi.org/10.22034/pmj.2025.2058206.1058

Farnaz Eghbalpour, Farnaz Eghbalpour

Abstract Systemic lupus erythematosus (SLE) is a multifaceted autoimmune disorder characterized by immune dysregulation and multi-organ involvement. Central to its pathogenesis is the CD154/CD40 signaling axis, which orchestrates key immunological processes, including T-B cell collaboration, dendritic cell activation, and cytokine production. Recent findings have expanded the scope of CD154 beyond its classical receptor CD40, identifying integrins as alternative receptors, thus broadening its biological impact. These discoveries underline the complexity of CD154's role in SLE and its potential as a therapeutic target. First-generation CD154/CD40-targeted therapies showed promise but were hindered by thromboembolic complications. However, second-generation therapeutics, including monoclonal antibodies, small molecules, and gene-editing technologies, exhibit improved safety and efficacy profiles. This review delves into the molecular and cellular mechanisms of CD154 in SLE, explores its emerging roles through integrin interactions, and evaluates the therapeutic advancements targeting this axis. The findings highlight CD154 as a central mediator in SLE pathogenesis and a compelling target for innovative treatment strategies.

An Ethnographic Review of Medicinal Plants Used for Alleviating Menstrual Pain in the Western Border Ethnobotany of Iran

Articles in Press, Accepted Manuscript, Available Online from 01 May 2025

https://doi.org/10.22034/pmj.2025.2059289.1061

Alireza Soleimani Mamalo, Shabnam Vazifekhah

Abstract Introduction: In this context, the use of medicinal plants as a natural and effective remedy for relieving Menstrual pain has been acknowledged in the western border region of Iran, serving as an alternative or complementary therapeutic approach. The aim of this study is to identify the medicinal plants employed in this region of Iran for the treatment of menstrual pain.
Methodology: This review study employed keywords such as medicinal plants, Iran, menstrual pain, and the provinces of West Azerbaijan, East Azerbaijan, Ardabil, Kurdistan, Kermanshah, Ilam, Khuzestan, and their cities, along with ethnobotany terms. Databases such as Google Scholar, SID, MegaIran, PubMed, and Scopus were utilized for article searches. Ethnobotanical articles related to the topic were selected for text review.
Results: Based on the ethnobotanical review, it was identified that in the cities and provinces of the western border region of Iran, medicinal plants such as fennel, wild parsley, shepherd's purse, black cumin, thyme, dandelion, rue, safflower, myrtle, European hornbeam, Kurdistan pistachio, mint, marshmallow root, male orchid, yarrow, agrimony, nettle, bitter herb, verbena, horsetail, periwinkle, marigold, saffron, wild thyme, savory, rhubarb, and eastern chamomile are commonly used for managing, controlling, and treating menstrual pain. Notably, the highest diversity of plant species was observed in the regions of Behbahan, Khuzestan, and Zrewar, Kurdistan. Leaves were the most commonly used plant part, and the Asteraceae and Lamiaceae families presented the highest number of species, indicating the rich diversity of medicinal and traditional plant applications.
Conclusion: The findings of this study demonstrate that the local communities in the western border region of Iran possess extensive knowledge regarding the use of medicinal plants for alleviating menstrual pain. Documenting and scientifically exploring this knowledge could lay the groundwork for the development of effective and natural herbal medicines in the domain of women’s health.

The Use of Bacteriophages in Cancer Therapy

Articles in Press, Accepted Manuscript, Available Online from 28 October 2024

https://doi.org/10.22034/pmj.2024.2044427.1042

Sanaz Khosravi

Abstract Cancer is a catastrophic illness with a significant worldwide fatality rate, anticipated to rise in the next years. Contemporary treatment modalities, including chemotherapy and radiation therapy, include constraints such as adverse effects, inconsistent efficacy, elevated expenses, and restricted accessibility. Bacteriophages have arisen as multifaceted instruments in bioengineering, with significant promise in tissue engineering, vaccine formulation, and immunotherapy. Bacteriophages are being used extensively in several fields of biotechnology and medicine, with cancer treatment being the most compelling application. Numerous studies are increasingly validating the effectiveness and safety of phage-based vectors as systemic delivery vehicles for therapeutic genes and medicines in cancer treatment. Moreover, the genetic composition of phages may be used for the creation of innovative DNA vaccines and antigen display systems, since they provide a highly structured and repeated presentation of antigens to immune cells. Bacteriophages have created novel opportunities for the precise targeting of certain molecular determinants in cancer cells. Phages may serve as anticancer agents and as carriers for imaging compounds and medicines. This article introduces bacteriophage and examines the performance of bacteriophages and bacteriophage engineering in targeted cancer treatment.

Polycystic ovary syndrome and genetic factors influencing its development: A review article

Polycystic ovary syndrome and genetic factors influencing its development: A review article

Volume 6, Issue 23, Autumn 2021, Pages 25-29

https://doi.org/10.22034/pmj.2021.249631

Tohid Piri-Gharaghie

Abstract Polycystic ovary syndrome (PCOS) is a common infertility disorder, affecting a significant proportion of the global population. This syndrome has been one of the most controversial entities in gynecological endocrinology for many years. Both genes and the environment contribute to PCOS. Obesity, exacerbated by poor dietary choices, and physical inactivity, worsens PCOS in susceptible individuals. PCOS is a complex and heterogeneous disorder characterized by hyperandrogenemia, hyperinsulinemia, insulin resistance, and chronic anovulation. Many candidate genes have been identified to be one of the causes of PCOS. Different studies have been carried out to find the genetic correlation of PCOS. It is essential to carry out such studies that identify the clear cause of PCOS and its genetic association and hormonal disbalance. Currently, PCOS is considered a polygenic trait that might result from the interaction of susceptible and protective genomic variants and environmental factors, during either prenatal or postnatal life.

Exploring the Attitudes, Beliefs and Perceptions of Undergraduate and Graduate Students in Bangladesh towards Precision Medicine and Pharmacogenomics Practice: A Qualitative Study

Exploring the Attitudes, Beliefs and Perceptions of Undergraduate and Graduate Students in Bangladesh towards Precision Medicine and Pharmacogenomics Practice: A Qualitative Study

Volume 8, Issue 29, Spring 2023, Pages 14-24

https://doi.org/10.22034/pmj.2023.705459

Nashrifa Israt Khanom, Saima Nur, Sheikh Sabrina Mustari, Omme Jamila, Abu Sa A Dat, Md Mehade Hasan, Mushfiquzzaman Mahim, Farhana Faiza Bristy, Nasrin Tamanna, Md.Moshrraf Hossen, Swapan Kumar Das, Tanvir Ahmed, Md. Ashrafuzzaman Sapon, Md. Shafiqul Islam, Md. Monirul Islam

Abstract The aim of this study is to investigate the attitude, beliefs, and perceptions among undergraduate and graduate students toward precession medicine (PM) and pharmacogenomics (PGx) practice. A cross-sectional survey is conducted amongst students from different universities in Bangladesh.The results of the survey showed that the majority of students had a positive attitude towards precision medicine and pharmacogenomics, perceiving it as a means to improve diagnosis and treatment accuracy. Furthermore, many students also expressed a willingness to learn more about precision medicine and pharmacogenomics, suggesting that there is potential for these practices to be utilized in Bangladesh. Particularly in this study, 337 students from life science and relevant programs participated. From this study, it is shown that 84% of graduate students and 74% of undergraduate students thought PM is a promising healthcare model. In addition, 39% of students are highly encouraged to pursue their post-graduation in the subject areas of PGx and PM to support patients. The majority (62%) thought that patient privacy was the ethical concern most closely related to pharmacogenomic testing, while 19% of respondents thought that data confidentiality was the key issue. The results provide insight into the potential of precision medicine and pharmacogenomics in Bangladesh and suggest that further research into the attitudes of healthcare professionals should be conducted in order to take full advantage of the potential of these practices.

Microplastic Neurotoxicity: Pathways, Mechanisms, and Implications for Neurodegenerative Disease

Microplastic Neurotoxicity: Pathways, Mechanisms, and Implications for Neurodegenerative Disease

Volume 10, Issue 37, Spring 2025, Pages 31-38

https://doi.org/10.22034/pmj.2025.2058727.1060

Shabnam Radbakhsh, Rezvan Norouzzadeh

Abstract This review synthesizes and elaborates on current studies examining the neurotoxic effects of microplastics, emphasizing their mechanisms of entry into the central nervous system and their possible involvement in the development of neurodegenerative disorders. The pervasive presence of microplastics in the environment has heightened concerns about their accumulation in biological systems, particularly their capacity to traverse biological boundaries and engage with neuronal tissues. This article seeks to synthesize and critically evaluate the existing scientific literature on microplastic neuroinvasion, concentrating on the mechanisms through which these particles penetrate the blood-brain barrier (BBB) specifically via transcellular, paracellular, or Trojan horse pathways—and their ensuing effects on neuronal homeostasis.

We investigate the physiological and molecular reactions triggered by microplastics, encompassing oxidative stress induction, mitochondrial failure, neuroinflammation, and synaptic disruption. These pathogenic processes may facilitate the onset and advancement of several neurodegenerative disorders, including Alzheimer’s disease, by intensifying amyloid-beta aggregation, tau phosphorylation, and neuroimmune activation. Additionally, we examine the burgeoning epidemiological and experimental evidence associating microplastic exposure with cognitive deterioration and neuronal impairment.

This review offers a thorough analysis of microplastic neurotoxicity by evaluating both in vitro and in vivo studies, with the objective of elucidating the potential neurological hazards associated with these environmental contaminants. We emphasize significant deficiencies in existing research and propose future avenues, encompassing enhanced detection techniques, public health initiatives, and efforts to reduce human exposure to microplastics.

Comparison of different methods of DNA extraction from paraffin-embedded tissues

Comparison of different methods of DNA extraction from paraffin-embedded tissues

Volume 5, Issue 17, Spring 2020, Pages 5-8

https://doi.org/10.22034/pmj.2020.43452

Ramadhan Ibrahim, Saeed Megdadi, Sareh Bakhshandeh bavarsad, Najme Shojaei

Abstract The most common human archival specimens are formalin-fixed and paraffin-embedded tissues. PCR-based techniques have been coupled with new developments in the extraction of DNA from FFPE. Herein, we report the results of a comparison of different methods of DNA extraction from FFPE specimens, including phenol-chloroform, salting-out, and silica-based commercial kits. Results showed no significant differences between the amounts of DNA obtained from each of the extraction methods studied; however, the salting-out DNA extraction method described is much easier and less toxic than the phenol–chloroform method.

Increased expression of the lnc H19 gene in the plasma of people with breast cancer

Increased expression of the lnc H19 gene in the plasma of people with breast cancer

Volume 5, Issue 17, Spring 2020, Pages 12-14

https://doi.org/10.22034/pmj.2020.43454

kazhaleh Mohammadi, Sadegh Shojaei Baghini, Mohammad Ali Saremi

Abstract The majority of ncRNAs are known as long non-coding RNAs (lncRNAs) whose length exceeds 200 nucleotides. H19, a lncRNA, is the transcription product of the H19 gene, an oncogene in breast cancer, and is highly expressed in cancer tissues compared with normal tissues. The expression level of H19 is associated with the oncogenesis, proliferation, invasion, metastasis, and drug resistance of breast cancer. H19 expression levels were detected in breast cancer plasma using qRT-Real-Time PCR assay in 50 breast cancer samples and 50 healthy control samples. The results showed that the expression of this gene in both the tissue and the plasma of patients increased compared to that of healthy individuals.

Analysis of EGFR gene mutations in tissue samples of lung cancer tumors

Analysis of EGFR gene mutations in tissue samples of lung cancer tumors

Volume 5, Issue 17, Spring 2020, Pages 1-4

https://doi.org/10.22034/pmj.2020.43451

Blnd Ibrahim Mohammed, Amir Mohammadi, Nafise Poorhasan

Abstract Lung cancer is the leading cause of cancer deaths worldwide. Approximately 25% of nonsmall-cell lung cancers have mutations in the EGFR gene, most of which occur in hotspot regions in exons 18, 19, 20, and 21. In-frame deletions in exon 19 (~50%) and the L858R point mutation in exon 21 (~40%) are associated with a favorable response to EGFR tyrosine kinase inhibitors. In this study, mutations of two exons of 19 and 21 in 50 lung cancer tumor samples were investigated by the sequence method. From 50 lung cancer patients, 8 (16%) patients had an L858R (c.2573T>G) mutation, 6 (12%) patients had deletion type 1a mutation, and one patient had deletion type 1b mutation. Examining the sequence of candidate genes associated with lung cancer can be very important in choosing the right treatment approach.

Relationship Between FGFR4 Gene rs351855 G/A Polymorphism and the Risk of Lung Cancer in the Northern Provinces

Relationship Between FGFR4 Gene rs351855 G/A Polymorphism and the Risk of Lung Cancer in the Northern Provinces

Volume 6, Issue 22, Summer 2021, Pages 6-9

https://doi.org/10.22034/pmj.2021.246863

Ghadir A Jamal, Hussam Saadi Aziz

Abstract Lung cancer is the leading cause of cancer death in men and the second leading cause of cancer death in women worldwide. FGFR is involved in a variety of cellular processes including angiogenesis, wound healing, tissue repair, and tumorigenesis. Recently, a common polymorphism in the transmembrane domain of the FGFR4 gene, Gly388Arg, has been reported to correlate with alteration of cell migration in vitro and with disease progression and/or survival in breast, colon, prostate and lung cancer. To evaluate the prognostic significance of the FGFR4 Gly388Arg polymorphism in lung cancer, we analyzed a case-control study of 110 lung cancer patients and 90 healthy control. Genomic DNA from whole-blood specimens was extracted using Salting-out method. Quality of DNA was evaluated by electrophoresis. To determine the distribution of FGFR4 Arg388 and FGFR4 Gly388 alleles in lung carcinoma patients, RFLP-PCR was used. In this study demonstrated that there was no relationship between polymorphism of FGFR4 Gly388Arg gene and lung cancer. Also, no significant relationship was observed between this polymorphism and clinical and pathological features of patients. It is suggested that the large casecontrol studies are needed to detect genetic determinants affecting patients’ prognosis, with the promise of targeting these putative genetic determinants to provide new therapeutic tools for patients with lung cancer.

The Multifaceted Role of CD154 in SLE: Pathogenesis, Receptor Interactions, and Emerging Therapies

The Multifaceted Role of CD154 in SLE: Pathogenesis, Receptor Interactions, and Emerging Therapies

Articles in Press, Accepted Manuscript, Available Online from 01 May 2025

https://doi.org/10.22034/pmj.2025.2058206.1058

Farnaz Eghbalpour, Farnaz Eghbalpour

Abstract Systemic lupus erythematosus (SLE) is a multifaceted autoimmune disorder characterized by immune dysregulation and multi-organ involvement. Central to its pathogenesis is the CD154/CD40 signaling axis, which orchestrates key immunological processes, including T-B cell collaboration, dendritic cell activation, and cytokine production. Recent findings have expanded the scope of CD154 beyond its classical receptor CD40, identifying integrins as alternative receptors, thus broadening its biological impact. These discoveries underline the complexity of CD154's role in SLE and its potential as a therapeutic target. First-generation CD154/CD40-targeted therapies showed promise but were hindered by thromboembolic complications. However, second-generation therapeutics, including monoclonal antibodies, small molecules, and gene-editing technologies, exhibit improved safety and efficacy profiles. This review delves into the molecular and cellular mechanisms of CD154 in SLE, explores its emerging roles through integrin interactions, and evaluates the therapeutic advancements targeting this axis. The findings highlight CD154 as a central mediator in SLE pathogenesis and a compelling target for innovative treatment strategies.

Publication Information
Indexing and Abstracting

Keywords Cloud